Scenario projections of COVID-19 burden in the US, 2024-2025
JAMA Network Open
About The Study:
In this decision analytical modeling study of COVID-19 burden in the U.S. in 2024 to 2025, ensemble projections suggested that although vaccinating high-risk groups had substantial benefits in reducing disease burden, maintaining the vaccine recommendation for all individuals had the potential to save thousands more lives. Despite divergence of projections from observed disease trends in 2024 to 2025—possibly driven by variant emergence patterns and immune escape—averted COVID-19 burden due to vaccination was robust across immune escape scenarios, emphasizing the substantial benefit of broader vaccine availability for all individuals.
Corresponding Author: To contact the corresponding author, Sung-mok Jung, PhD, email sungmok@ad.unc.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.32469)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article
About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
Journal
JAMA Network Open
Menstrual cycle and long COVID: A relation confirmed
Women suffering from long COVID have a greater risk1 of experiencing abnormal uterine bleeding2. The symptoms of the illness intensify during the perimenstrual and proliferative phases of the menstrual cycle, notably fatigue, headaches, and muscle pain. This bidirectional relationship between long COVID and menstrual disorders has been revealed by a French-British research team co-led by a CNRS researcher3. An inflammatory reaction is suspected of being behind this connection, after the discovery of an immune cell cluster in the endometrium of the patients receiving treatment. No abnormalities were detected in relation to ovarian hormones.
These conclusions, which were just published in Nature Communications, are based on a combination of three approaches: a study conducted among 12,187 British women; follow-up care for 54 women suffering from long COVID for three months; and analysis of blood and endometrial samples.
As long COVID affects 3-7% of the world’s population4, and is twice as prevalent among women than men, this novel study paves the way for new therapeutic prospects. It also underscores the importance of considering the menstrual cycle in long COVID biomarkers, as well as the need to develop therapies specifically adapted to women.
Notes
1 – Outside of a long COVID context, “abnormal” uterine bleeding already affects one in three people worldwide, causing anaemia and major socioeconomic impact.
2 – Compared to a control group, long COVID is associated with reporting more abundant and longer periods, in addition to bleeding between cycles, contrary to acute COVID.
3 – From the Montpellier Institute of Evolutionary Sciences (CNRS/IRD/Université de Montpellier).
4 – Approximately 400 million people are or have been affected by long COVID worldwide. In France, 4% of the population is concerned, or 2.7 million people.
Sources:
- “Long COVID science, research and policy.” Nature Medicine, 9 August 2024;
- Santepubliquefrance.fr : https://www.santepubliquefrance.fr/revues/articles-du-mois/2024/prevalence-du-covid-long-dans-la-population-adulte-generale-selon-differentes-definitions-et-selon-les-caracteristiques-de-l-infection-et-sociodemo
Journal
Nature Communications
Article Title
The potential bidirectional relationship between long COVID and menstruation.
Article Publication Date
16-Sep-2025
No comments:
Post a Comment